Symptom Status Predicts Patient Outcomes in Persons with HIV and Comorbid Liver Disease
Table 2
Measure comparisons by model variable for HIV and HIV + LD groups.
Variable measure
Overall ()
Group
Statistic
HIV ()
HIV + LD ()
n (%)/M (SD)
n (%)/M (SD)
n (%)/M (SD)
Chi-sq/t-test
df
Value
P value
Biological/physiological factors
CD4 count
455.94 (303.97)
492.25 (341.98)
435.43 (316.30)
Mann-Whitney
−2.01
.044
HIV viral load
Pearson (1)
3.35
.067
Detectable
199 (41.1)
102 (37.5)
97 (45.8)
Undetectable
285 (58.9)
170 (62.5)
115 (54.2)
Symptom status
Beck depression inventory-II
14.94 (11.54)
13.89 (11.68)
16.34 (11.22)
525
−2.42
.016
MOS-HIV mental summary score
45.44 (12.06)
46.77 (12.24)
43.63 (11.59)
520
2.96
.003
Functional status
Missed appointments
Pearson (1)
.835
.361
Yes
172 (33.0)
94 (31.3)
78 (35.1)
No
350 (67.0)
206 (68.7)
144 (64.9)
MOS-HIV physical summary score
41.80 (11.62)
43.47 (11.28)
39.51 (11.72)
520
3.90
<.001
Perception of illness
0.74 (0.19)
.74 (.18)
.731 (.19)
524
.72
.470
MOS-HIV health transition score
3.34 (1.02)
3.39 (1.01)
3.27 (1.02)
524
1.34
.182
Overall quality of life
Satisfaction with life scale
3.57 (1.49)
3.63 (1.44)
3.49 (1.56)
517
1.08
.280
We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.
